Epirubicin Hydrochloride

Epirubicin Hydrochloride

Form: Injection (IV)

Strength: 10 mg/5 mL, 50 mg/25 mL, 100 mg/50 mL

Reference Brands: Ellence® (US) , Farmorubicin®(EU)

Category: Oncology Cancer Care

Epirubicin Hydrochloride is a potent anthracycline chemotherapy agent widely used in treating breast, gastric, ovarian, lung, and bladder cancers. It works by inhibiting DNA synthesis, leading to effective cancer cell destruction. Available under brand names like Ellence® (US) and Farmorubicin® (EU), and in generic forms, Epirubicin is supplied as an IV injection in 10 mg, 50 mg, and 100 mg vial strengths. Manufactured in GMP-compliant facilities, it is ideal for hospital oncology departments and global pharmaceutical distributors. Epirubicin remains a trusted cancer treatment solution across EU and US markets, ensuring consistent quality and therapeutic efficacy.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Atezolizumab

Strength: 1200 mg/20 mL

Form: Intravenous infusion

Reference Brands: Tecentriq® (EU & US)

View Details Get Enquiry
Durvalumab

Strength: 120 mg/4 mL, 500 mg/10 mL

Form: Injection

Reference Brands: Imfinzi® (US & EU)

View Details Get Enquiry
Sunitinib

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg

Form: Tablet

Reference Brands: Sutent® (EU & US)

View Details Get Enquiry
Ifosfamide

Strength: 1 g/vial,2 g/vial, 3 g/vial

Form: Injection

Reference Brands: Ifex® (US), Holoxan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.